Nio Kouki, Yamashita Taro, Kaneko Shuichi
Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Marsico Hall 5229 M, 125 Mason Farm Rd, 27599, Chapel Hill, NC, USA.
Department of Gastroenterology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-Machi, 920-8641, Kanazawa, Ishikawa, Japan.
Mol Cancer. 2017 Jan 30;16(1):4. doi: 10.1186/s12943-016-0572-9.
Liver cancer is an often fatal malignant tumor with a high recurrence rate and chemoresistance. The major malignant phenotypes of cancer, including recurrence, metastasis, and chemoresistance, are related to the presence of cancer stem cells (CSCs). In the past few decades, CSCs have been identified and characterized in many tumors including liver cancer. Accumulated evidence has revealed many aspects of the biological behavior of liver CSCs and the mechanism of their regulation. Based on these findings, a number of studies have investigated eradication of liver CSCs. This review focuses on the recent advances in our understanding of the biology of liver CSCs and the development of strategies for their treatment.
肝癌是一种往往致命的恶性肿瘤,复发率高且具有化疗耐药性。癌症的主要恶性表型,包括复发、转移和化疗耐药,都与癌症干细胞(CSCs)的存在有关。在过去几十年里,已在包括肝癌在内的许多肿瘤中鉴定并表征了CSCs。越来越多的证据揭示了肝脏CSCs生物学行为的诸多方面及其调控机制。基于这些发现,许多研究对清除肝脏CSCs进行了探索。本综述重点关注我们对肝脏CSCs生物学认识的最新进展及其治疗策略的发展。